Design, synthesis, and evaluation of peptides with estrogen‐like activity

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Biopolymers

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/bip.20133PMID 15468062
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 2. Clinical considerations and new agents.

  2003cited by this paper
• Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 1. Receptor interactions.

  2003cited by this paper
• How estrogen‐specific proteins discriminate estrogens from androgens: A common steroid‐binding site architecture

  2003cited by this paper
• Molecular basis for the subtype discrimination of the estrogen receptor-beta-selective ligand, diarylpropionitrile.

  2003cited by this paper
• Elucidation of the molecular mechanism of action of selective estrogen receptor modulators.

  2002cited by this paper
• Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study.

  2002cited by this paper
• A synthetic peptide with estrogen-like activity derived from a phage-display peptide library.

  2002cited by this paper
• Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism

  2002cited by this paper
• Synthesis and biological evaluation of a novel series of furans: ligands selective for estrogen receptor alpha.

  2001cited by this paper
• Flexible estrogen receptor modulators: design, synthesis, and antagonistic effects in human MCF-7 breast cancer cells.

  2001cited by this paper
• Design and synthesis of peptides that bind alpha-bungarotoxin with high affinity.

  2001cited by this paper
• Nuclear Receptors, Coregulators, Ligands, and Selective Receptor Modulators

  2001cited by this paper
• Synthesis and biological evaluation of a novel series of furans: Ligands selective for estrogen receptor α

  2001cited by this paper
• Design and synthesis of peptides that bind α-bungarotoxin with high affinity

  2001cited by this paper
• Structural aspects of agonism and antagonism in the oestrogen receptor.

  2000cited by this paper
• Relative binding affinity does not predict biological response to xenoestrogens in rat endometrial adenocarcinoma cells.

  2000cited by this paper
• Solid-phase synthesis of tetrasubstituted pyrazoles, novel ligands for the estrogen receptor.

  2000cited by this paper
• The estrogen receptor family.

  1999cited by this paper
• The measurement of the isoflavone daidzein by time resolved fluorescent immunoassay: a method for assessment of dietary soya exposure.

  1998cited by this paper
• Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β.

  1998cited by this paper
• Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta.

  1998cited by this paper
• Basic guide to the mechanisms of antiestrogen action.

  1998cited by this paper
• Effects of gonadal steroids and their antagonists on DNA synthesis in human vascular cells.

  1998cited by this paper
• The beneficial effects of treatment with tamoxifen and anti‐oestradiol antibody on experimental systemic lupus erythematosus are associated with cytokine modulations

  1997cited by this paper
• Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites.

  1997cited by this paper
• Molecular basis of agonism and antagonism in the oestrogen receptor

  1997cited by this paper
• Synaptic remodeling in the arcuate nucleus during the estrous cycle is induced by estrogen and precedes the preovulatory gonadotropin surge.

  1996cited by this paper
• Yeast RSP5 and its human homolog hRPF1 potentiate hormone-dependent activation of transcription by human progesterone and glucocorticoid receptors

  1996cited by this paper
• Screening and characterization of estrogenic activity from a hydroxystilbene library.

  1995cited by this paper
• Regulation of progesterone receptor gene expression and growth in the rat uterus: modulation of estrogen actions by progesterone and sex steroid hormone antagonists.

  1993cited by this paper
• Suggestions for "safe" residue substitutions in site-directed mutagenesis.

  1991cited by this paper
• Biotinylated protein A in immunoassay.

  1990cited by this paper
• Two-site and competitive chemiluminescent immunoassays.

  1990cited by this paper
• Solid‐phase peptide synthesis: a practical approach

  1990cited by this paper
• The steroid and thyroid hormone receptor superfamily.

  1988cited by this paper
• Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation award lecture.

  1988cited by this paper
• The classification of amino acid conservation.

  1986cited by this paper
• Monoclonal antibodies : basic principles, experimental and clinical applications in endocrinology

  1986cited by this paper
• On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone.

  1984cited by this paper
• Continuous cultures of fused cells secreting antibody of predefined specificity

  1975cited by this paper
• Physiology of reproduction.

  1948cited by this paper

• Microfluidic NF/RO separation: Cell design, performance and application

  2012cites this paper
• Bisphenyl-Polymer/Carbon-Fiber-Reinforced Composite Compared to Titanium Alloy Bone Implant.

  2011cites this paper
• The effects of peptides with estrogen‐like activity on cell proliferation and energy metabolism in human derived vascular smooth muscle cells

  2010cites this paper
• Restrain of bone growth by estrogen-mimetic peptide-1 (EMP-1): a micro-computed tomographic study.

  2009influential citation
• Engineered Systems for Detection and Discovery of Nuclear Hormone‐Like Compounds

  2008cites this paper
• Solid-phase organic synthesis (SPOS) of modulators of estrogenic and androgenic action.

  2006cites this paper
• The substrate-binding domain of 21-hydroxylase, the main autoantigen in autoimmune Addison's disease, is an immunodominant T cell epitope.

  2006cites this paper